Apoptosis Assay Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921874|
|出版日期||內容資訊||英文 112 Pages
|全球細胞凋亡化驗市場:成長，趨勢，及預測(2020年∼2025年) Apoptosis Assay Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 112 Pages||
The major factors attributing to the growth of the apoptosis assay market are the rising incidence of infectious and chronic diseases such as autoimmune diseases, cancer, and others. The rise in the population suffering from chronic and autoimmune diseases are propelling the demand for market growth. In 2018, as per the AARDA (AMERICAN AUTOIMMUNE RELATED DISEASE ASSOCIATION) statistics, around 50 million Americans have an autoimmune disease, and this number is expected to rise in the future. And there are few more factors which are playing crucial roles in taking the apoptosis assay market to the next level, among them one is on-going developments related to apoptosis-modulating drugs which are expected to further propel the growth of the global apoptosis assays market. However, Increasing demand for high-content diagnosis and clinical research for cancer, in particular, is indeed bolstering market growth during the forecasted period.
Apoptosis is a form of programmed cell death that occurs in multicellular organisms. Apoptosis Assay aims to detect if a cell has apoptosis or not. It identifies and quantifies cell events related to programmed cell death, involving caspase initiation, phosphatidylserine (PS) cell surface exposure and DNA fragmentation.
Assay Kits Segment is Expected to Hold the Largest Market Share in the Apoptosis Assay Market
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall apoptosis assay market, throughout the forecast period. This is owing to factors such as the rising incidence of chronic diseases such as cancer and the availability of advanced healthcare infrastructure among the major factors. In North America region, the United States holds the largest market share owing to the factors such as increasing number of population suffering from autoimmune diseases and chronic disease, along with the rising geriatric population and developments related to apoptosis-modulating drugs in the country, is anticipated to stimulate the demand in this region.
The apoptosis assay market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Ans some prominent players are vigorously making acquisitions and new product launches with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Bio-Rad Laboratories, Merck KGaA, GE Healthcare, and Becton, Dickinson, and Company.